FrancophonIA/ELRC3.0 huggingface dataset:
English: • For your next dose, be sure to firmly push and hold the injection button in and slowly count to 5 before removing needle from skin.
Slovenian: • Pri naslednjem odmerjanju zagotovite, da boste gumb za injiciranje čvrsto pritisnili in držali ter počasi šteli do 5, preden boste iz kože izvlekli iglo.
English: Byetta is used with other diabetic medicines called metformin, sulphonylureas, thiazolidinediones and basal or long acting insulins.
Slovenian: Zdravilo Byetta uporabljamo skupaj z drugimi zdravili za sladkorno bolezen, ki se imenujejo metformin, sulfonilsečnine, tiazolidindioni in bazalni ali dolgo delujoči insulini.
English: If a patient wishes to become pregnant, or pregnancy occurs, treatment with exenatide should be discontinued.
Slovenian: Ženske v rodni dobi Če bolnica želi zanositi ali zanosi, moramo zdravljenje z eksenatidom prekiniti.
English: Your doctor may tell you to use Byetta 5 micrograms twice a day to start with.
Slovenian: Vaš zdravnik vam lahko za začetek predpiše zdravilo Byetta 5 mikrogramov (µg) dvakrat na dan.
English: Each pen has 60 doses to provide 30 days of twice-aday injections.
Slovenian: En injekcijski peresnik vsebuje 60 odmerkov za zagotavljanje injekcije dvakrat na dan za 30 dni.
English: - If you have severe problems with slowstomach emptying or food digestion, asthe use of this medicine is not recommended.
Slovenian: - Če imate hude težave s počasnim praznjenjem želodca ali prebavo hrane, se jemanja zdravila Byetta ne priporoča.
English: Immediate-release exenatide should not be administered after a meal.
Slovenian: Eksenatid v obliki s takojšnjim sproščanjem ne smemo dajati po obroku.
English: The patient should be instructed to discard the needle after each injection.
Slovenian: Bolnika naučite, da iglo po vsakem injiciranju zavrže.
English: Note: If you see several drops of Byetta leaking from the needle after the injection, the injection button was not pushed in all the way.
Slovenian: Opomba: Če po injiciranju nekaj kapelj zdravila Byetta izteka iz igle, gumba za injiciranje niste pritisnili do konca.
English: Byetta should not be used if particles appear or if the solution is cloudy and/or coloured.
Slovenian: Zdravila Byetta ne smete uporabljati, če se v raztopini pojavijo delci ali je raztopina motna in/ali obarvana.
English: Exenatide increases, on a glucose-dependent basis, the secretion of insulin from pancreatic beta cells.
Slovenian: V odvisnosti od glukoze eksenatid poveča izločanje insulina iz beta celic trebušne slinavke.
English: Make sure needle is on straight and screwed on all the way.
Slovenian: Prepričajte se, da je igla privita naravnost in do konca.
English: There were no clinically significant differences in the incidence of hypoglycaemic episodes in the immediate-release exenatide compared to the placebo group (25% and 29% respectively).
Slovenian: Razlike v pogostnosti epizod hipoglikemije pri dajanju eksenatida v obliki s takojšnjim sproščanjem in placeba niso bile klinično pomembne (25 % oziroma 29 %).
English: Where should I inject Byetta?
Slovenian: Kam naj injiciram zdravilo Byetta?
English: Immediate-release exenatide reduced HbA1c and body weight in patients treated for 30 weeks in three placebo-controlled studies, whether the immediate-release exenatide was added to metformin, a sulphonylurea or a combination of both.
Slovenian: Eksenatid v obliki s takojšnjim sproščanjem je zmanjšalo HbA1c in telesno maso pri bolnikih, ki so jih v treh s placebom nadzorovanih študijah zdravili 30 tednov, neodvisno od tega ali je bilo eksenatid v obliki s takojšnjim sproščanjem dodano metforminu, sulfonilsečnini ali kombinaciji obeh.
English: Weight loss of 2.3 kg (2.6%) was achieved with immediate-release exenatide in the 26-week study and a loss of 2.5 kg (2.7%) in a 52-week study whereas treatment with insulin was associated with weight gain.
Slovenian: Z eksenatidom v obliki s takojšnjim sproščanjem so v 26 tedenski študiji dosegli zmanjšanje mase za 2,3 kg (2,6 %) in v 52-tedenski študiji za 2,5 kg (2,7 %), medtem ko je bilo zdravljenje z insulinom povezano s povečanjem mase.
English: There was no significant difference in body weight between treatment groups in change from baseline to endpoint (-1.4 versus -0.8 kg).
Slovenian: Med izhodiščno in končno vrednostjo telesne mase ni bilo značilne razlike med skupinama zdravljenja (-1,4 proti -0,8 kg).
English: In patients where existing therapy also included a sulphonylurea the incidence of patients with at least one minor hypoglycaemic episode was 48% and 54% respectively and one patient reported major hypoglycaemia.
Slovenian: Pri bolnikih, pri katerih je obstoječe zdravljenje vključevalo tudi sulfonilsečnino, je bila pogostnost blage hipoglikemije 48 % oziroma 54 %, en bolnik pa je poročal o hudi hipoglikemiji.
English: Similar exposure is achieved with subcutaneous administration of exenatide in the abdomen, thigh, or arm.
Slovenian: Podobno izpostavljenost dosežemo s subkutanim dajanjem eksenatida v trebuh, stegno ali roko.
English: Of the immediate-release exenatide patients, 12% were treated with a thiazolidinedione and immediate-release exenatide and 82% were treated with a thiazolidinedione, metformin and immediate-release exenatide.
Slovenian: 12 % bolnikov na eksenatidu v obliki s takojšnjim sproščanjem je bilo zdravljenih s tiazolidindionom in eksenatidom v obliki s takojšnjim sproščanjem, 82 % pa s tiazolidindionom, metforminom in eksenatidom v obliki s takojšnjim sproščanjem.
English: When immediate-release exenatide is used in combination with basal insulin, the dose of basal insulin should be evaluated.
Slovenian: Ko se eksenatid v obliki s takojšnjim sproščanjem uporablja v kombinaciji z bazalnim insulinom, je potrebno ovrednotiti odmerek bazalnega insulina.
English: You will not need to test your sugar levels on a day-by-day basis to set the dose of Byetta.
Slovenian: Za nastavitev ustreznega odmerka zdravila Byetta vam ne bo potrebno dnevno preverjati ravni sladkorja.
English: Exenatide slows gastric emptying thereby reducing the rate at which meal-derived glucose appears in the circulation.
Slovenian: Eksenatid upočasni praznjenje želodca, s čimer zmanjša hitrost, s katero se glukoza iz obroka pojavi v krvnem obtoku.
English: Byetta with food
Slovenian: Zdravilo Byetta skupaj s hrano
English: • Remove the needle after each injection.
Slovenian: • Iglo odstranite po vsakem injiciranju.
English: See Commonly Asked Questions, numbers 5 and 9, in Section 4 of this user manual.
Slovenian: Glejte Pogosta vprašanja, številki 5 in 9, v Poglavju 4 tega Priročnika za uporabo.
English: A reduction in body weight was seen in patients treated with immediate-release exenatide irrespective of the occurrence of nausea although the reduction was larger in the group with nausea (mean reduction 2.4 kg versus 1.7 kg) in the long-term controlled studies of up to 52 weeks.
Slovenian: Pri bolnikih zdravljenih z eksenatidom v obliki s takojšnjim sproščanjem so zmanjšanje telesne mase opazili neodvisno od pojava navzee, čeprav je bilo v do 52 tednov trajajočih dolgoročnih nadzorovanih študijah zmanjšanje večje v skupini z navzeo (povprečno zmanjšanje 2,4 kg proti 1,7 kg).
English: In patients with moderate renal impairment (creatinine clearance 30-50 ml/min), dose escalation from 5 mcg to 10 mcg should proceed conservatively (see section 5.2).
Slovenian: Pri bolnikih z zmerno okvaro ledvic (očistek kreatinina 30-50 ml/min) previdno višamo odmerek od 5 μg do 10 μg (glejte poglavje 5.2).
English: USER MANUAL CONTENTS
Slovenian: VSEBINA PRIROČNIKA ZA UPORABNIKA
English: • Byettais injected twice a day,the pen contains enough medicine for 30 days.
Slovenian: • Zdravilo Byetta se injicira dvakrat na dan, tako da injekcijski peresnik vsebuje količino zdravila za 30 dni.
English: WHAT YOU NEED TO KNOW ABOUT YOUR BYETTA PEN
Slovenian: KAJ MORATE VEDETI O VAŠEM INJEKCIJSKEM PERESNIKU BYETTA
English: Byetta is available in pack sizes of 1 and 3 pre-filled pens.
Slovenian: Zdravilo je na voljo v velikostih pakiranja po 1 in 3 napolnjeni injekcijski peresniki.
English: A trend for a decrease in triglycerides has been observed with weight loss.
Slovenian: Z zmanjšanjem mase so opazili trend za zmanjšanje trigliceridov.
English: Your Byetta pen is suitable for use with Becton, Dickinson and Company pen injection needles.
Slovenian: Vaš injekcijski peresnik Byetta je primeren za uporabo z injekcijskimi iglami za peresnik proizvajalca Becton, Dickinson and Company.
English: • Use a Byettapen for only 30 days after setting up a new pen for first use.
Slovenian: • Injekcijski peresnik Byetta uporabljajte samo 30 dni po pripravi novega injekcijskega peresnika za prvo uporabo.
English: However, since market introduction, increased INR (International Normalized Ratio) has been reported spontaneously during concomitant use of warfarin and exenatide.
Slovenian: Vendar so od uvedbe na trg med sočasno uporabo varfarina in eksenatida v obliki s takojšnjim sproščanjem spontano poročali o povišanem INR (International Normalised Ratio).
English: • Check pen label to make sure it is your 10 microgram pen.
Slovenian: • Preverite oznako na injekcijskem peresniku, da zagotovite uporabo vašega 10 µg injekcijskega peresnika.
English: 5 mcg: Each pre-filled pen contains 60 doses (approximately 1.2 ml of solution).
Slovenian: 5 µg: En napolnjen injekcijski peresnik vsebuje 60 odmerkov (približno 1,2 ml raztopine).
English: Non-clinical data reveal no special hazards for humans based on conventional studies of safety pharmacology, repeat-dose toxicity, or genotoxicity.
Slovenian: Predklinični podatki na osnovi običajnih študij farmakološke varnosti, toksičnosti pri ponavljajočih odmerkih ali genotoksičnosti ne kažejo posebnih tveganj za človeka.
English: • You have firmly pushed the injection button in all the way until it stops and
Slovenian: • ste čvrsto pritisnili gumb za injiciranje vse do konca in
English: • Check pen label to make sure it is your 5 microgram pen.
Slovenian: • Preverite oznako na injekcijskem peresniku, da zagotovite uporabo vašega 5 µg injekcijskega peresnika.
English: In patients with end-stage renal disease receiving dialysis, single doses of immediate-release exenatide 5 mcg increased frequency and severity of gastrointestinal adverse reactions.
Slovenian: Pri bolnikih s končno stopnjo bolezni ledvic na dializi so enkratni odmerki eksenatida v obliki s takojšnjim sproščanjem 5 μg povečali pogostnost in resnost neželenih učinkov na prebavila.
English: Pack size of 1 and 3 pens.
Slovenian: Velikost pakiranja je 1 in 3 injekcijski peresniki.
English: • Store in a refrigerator (2 ºC to 8 ºC).
Slovenian: • Shranjujte v hladilniku (2  C do 8 C).
English: • The dose knob was not turned all the way.
Slovenian: • Gumba za odmerjanje niste obrnili do konca.
English: In clinical trials, background therapies included metformin, a sulphonylurea, a thiazolidinedione, or a combination of oral glucose-lowering medicinal products.
Slovenian: Osnovna zdravljenja so v kliničnih študijah obsegala metformin, sulfonilsečnino, tiazolidindion ali kombinacijo peroralnih zdravil za zniževanje glukoze.
English: One to deliver doses of 5micrograms and one 10micrograms.
Slovenian: Eden za dajanje odmerkov 5 mikrogramov (µg) in drugi 10 mikrogramov (µg).
English: No pharmacokinetic study has been performed in patients with hepatic insufficiency.
Slovenian: Pri bolnikih z okvaro jeter niso opravili nobenih farmakokinetičnih študij.
English: In a 24-week study, where either insulin lispro protamine suspension or insulin glargine was added to existing therapy of immediate-release exenatide and metformin, metformin and sulphonylurea or metformin and pioglitazone, HbA1c was lowered by 1.2% (n=170) and by 1.4% (n=167) respectively from a baseline of 8.2%.
Slovenian: V 24-tedenski študiji, kjer so že obstoječem zdravljenju z eksenatidom v obliki s takojšnjim sproščanjem in metforminom, metforminom in sulfonilsečnino ali metforminom in pioglitazonom dodali suspenzijo insulina lispro- protamin ali insulina glargin, se je vrednost HbA1c znižala za 1,2 % (n=170) oziroma 1,4 % (n=167) od začetne vrednosti 8,2 %.
English: Weight increase of 0.2 kg was observed for patients on insulin lispro protamine suspension and 0.6 kg for insulin glargine treated patients from a baseline of 102 kg and 103 kg respectively.
Slovenian: Pri bolnikih, ki so uporabljali suspenzijo insulina lispro-protamin, so opazili povečanje telesne mase za 0,2 kg, pri bolnikih, ki so uporabljali insulin glargin, pa za 0,6 kg od začetne vrednosti 102 kg oziroma 103 kg.
English: • Pull the dose knob out until appears.
Slovenian: • Izvlecite gumb za odmerjanje, da se pojavi
English: Section 1.
Slovenian: Poglavje 1.
English: Caution should be exercised in patients with a history of pancreatitis.
Slovenian: Pri bolnikih, ki so v preteklosti že imeli pankreatitis je potrebna previdnost.
English: It is unknown whether exenatide is excreted in human milk.
Slovenian: Dojenje Ni znano, ali se eksenatid izloča v materino mleko.
English: ready to pull dose knob out ready to turn to dose position ready to inject 10 micrograms (mcg)
Slovenian: Pripravljen za obračanje za nastavitev odmerka Pripravljen za injiciranje 10 mikrogramov (µg)
English: Injection Button
Slovenian: Gumb za injiciranje
English: When this medicine is used with a medicine that contains a sulphonylurea or an insulin, episodes of low blood sugar (hypoglycaemia, generally mild to moderate) can occur very commonly.
Slovenian: Pri uporabi tega zdravila skupaj z zdravilom, ki vsebuje sulfonilsečnino ali insulin, zelo pogosto lahko pride do epizod nizkega sladkorja v krvi (hipoglikemije, na splošno blage do zmerne).
English: In insulin-comparator studies immediate-release exenatide (5 mcg BID for 4 weeks, followed by 10 mcg BID) in combination with metformin and sulphonylurea significantly (statistically and clinically) improved glycaemic control, as measured by decrease in HbA1c.
Slovenian: V z insulinom primerjalnih študijah je eksenatid v obliki s takojšnjim sproščanjem (5 μg dvakrat na dan 4 tedne, nato 10 μg dvakrat na dan) v kombinaciji z metforminom in sulfonilsečnino značilno (statistično in klinično) izboljšalo glikemični nadzor merjen z zmanjšanjem HbA1c.
English: See the accompanying Pen User Manual for instructions for using the Byetta Pen.
Slovenian: Glejte priloženi Priročnik za uporabo injekcijskega peresnika za navodila za uporabo injekcijskega peresnika Byetta.
English: System organ class /adverse reaction terms
Slovenian: Organski sistem/Neželeni učinki
English: See Commonly Asked Questions, number 5, in Section 4 of this user manual.
Slovenian: Glejte Pogosta vprašanja, številka 5, v Poglavju 4 tega Priročnika za uporabo.
English: Ask your doctor if the time at which you take any tablets should be changed because this medicine slows stomach emptying and can affect medicines that need to pass through the stomach quickly, e.g.
Slovenian: Vprašajte svojega zdravnika, ali morate spremeniti čas jemanja katerih koli tablet, saj to zdravilo upočasni praznjenje želodca in lahko vpliva na zdravila, ki morajo hitro preiti skozi želodec, npr.: - na želodčni sok odporne tablete ali kapsule (na primer zaviralci protonske črpalke), ki se ne smejo predolgo zadrževati v želodcu, bo morda treba vzeti eno uro pred ali štiri ure po zdravilu
English: - Each millilitre (ml) of the solution for injection contains 0.25 milligrams (mg) of exenatide.
Slovenian: - En mililiter (ml) raztopine za injiciranje vsebuje 0,25 miligramov (mg) eksenatida.
English: Hepatic impairment No dosage adjustment is necessary in patients with hepatic impairment (see section 5.2).
Slovenian: Okvara jeter Pri bolnikih z okvaro jeter odmerka ni potrebno prilagajati (glejte poglavje 5.2).
English: Store in a refrigerator (2 ºC - 8 ºC).
Slovenian: Shranjujte v hladilniku (2 ºC - 8 ºC).
English: Proportion of patients (%) achieving HbA1c ≤ 7% (patients completing studies) Baseline weight (kg) Change of weight from baseline (kg)
Slovenian: Začetni HbA1c (%) Sprememba v HbA1c (%) glede na začetnega Odstotek bolnikov, ki so dosegli HbA1c ≤ 7 % Odstotek bolnikov, ki so dosegli HbA1c ≤ 7 % (bolniki, ki so dokončali študije)
English: NEW PEN SETUP - DO THIS ONE TIME ONLY
Slovenian: PRIPRAVA NOVEGA INJEKCIJSKEGA PERESNIKA - PRIPRAVITE SAMO ENKRAT
English: As blood glucose concentrations decrease, insulin secretion subsides.
Slovenian: Ko se koncentracija glukoze v krvi zniža, izločanje insulina upade.
English: In insulin-comparator controlled studies in which metformin and a sulphonylurea were concomitant medicinal products, the incidence for these adverse reactions was similar for insulin- and immediate-release exenatide-treated patients.
Slovenian: V z insulinom primerjalnih nadzorovanih študijah, v katerih so bolniki sočasno dobivali metformin in sulfonilsečnino, je bila incidenca teh neželenih učinkov podobna za bolnike zdravljene z insulinom in zdravilom BYETTA.
English: Note: If you cannot turn the dose knob, or if your pen leaks, your full dose has not been delivered.
Slovenian: Opomba: Če gumba za odmerjanje ne morete obračati v smeri urnega kazalca ali če iz vašega injekcijskega peresnika izteka, niste prejeli vašega celotnega odmerka.
English: Byetta contains metacresol Metacresol may cause allergic reactions.
Slovenian: Metakrezol lahko povzroči alergijske reakcije.
English: The New Pen Setup is done only once, just before each new pen is used for the firsttime.
Slovenian: Pripravo novega injekcijskega peresnika opravite samo enkrat, tik pred prvo uporabo vsakega novega injekcijskega peresnika.
English: When immediate-release exenatide was used in combination with a thiazolidinedione, the incidence of hypoglycaemia was similar to that of placebo in combination with a thiazolidinedione.
Slovenian: Ko so eksenatid v obliki s takojšnjim sproščanjem uporabili v kombinaciji z tiazolidindionom, je bila incidenca hipoglikemije podobna tisti pri placebu v kombinaciji z tiazolidindionom.
English: Subcutaneous use.
Slovenian: za subkutano uporabo
English: How do I clean my Byetta pen?
Slovenian: Kako naj očistim moj injekcijski peresnik Byetta?
English: STEP E Complete New Pen Setup
Slovenian: KORAK E Zaključite pripravo novega injekcijskega peresnika
English: • Avoid tightly pinching the skin before injecting.
Slovenian: • Kože pred injiciranjem ne stiskajte premočno.
English: Follow the steps next to the matching symbol.
Slovenian: Glede na simbol, sledite naslednjim korakom.
English: In a 24-week study, where either insulin lispro protamine suspension or insulin glargine was added to existing therapy of immediate-release exenatide and metformin or metformin plus thiazolidinedione the incidence of patients with at least one minor hypoglycaemic episode was 18% and 9% respectively and one patient reported major hypoglycaemia.
Slovenian: V 24-tedenski študiji, pri kateri so obstoječemu zdravljenju z eksenatidom v obliki s takojšnjim sproščanjem in metforminom ali metforminom s tiazolidindionom dodali suspenzijo insulina lisproprotamin ali insulina glargin, je bila pogostost bolnikov z vsaj eno blago hipoglikemično epizodo 18 % oziroma 9 %, pri enem bolniku pa je prišlo do hude hipoglikemije.
English: - Each dose of Byetta 10micrograms solution for injection (injection) contains 10micrograms exenatide in 40 microlitre.
Slovenian: - En odmerek zdravila Byetta 10 mikrogramov (µg) raztopina za injiciranje (injekcija) vsebuje 10 mikrogramov (µg) eksenatida v 40 mikrolitrih.
English: - Each dose of Byetta 5 micrograms solution for injection (injection) contains 5 micrograms exenatide in 20 microlitre.
Slovenian: - En odmerek zdravila Byetta 5 mikrogramov (µg) raztopina za injiciranje (injekcija) vsebuje 5 mikrogramov (µg) eksenatida v 20 mikrolitrih.
English: Section 1 - WHAT YOU NEED TO KNOW ABOUT YOUR BYETTA PEN Section 2 - GETTING STARTED: FOR FIRST TIME USERS OR NEW PENS Section 3 - ROUTINE USE: FOR PEOPLE WHO HAVE SET UP THEIR PEN Section 4 - COMMONLY ASKED QUESTIONS: FOR QUESTIONS RELATED TO THE PEN
Slovenian: Poglavje 1 - KAJ MORATE VEDETI O VAŠEM INJEKCIJSKEM PERESNIKU BYETTA Poglavje 2 - KAKO ZAČETI: ZA VSE, KI INJEKCIJSKI PERESNIK UPORABLJAJO
English: STEP 2 Attach the Needle
Slovenian: KORAK 2 Pritrdite iglo
English: Make sure that the 10 with the line under it is in the centre of the dose window.
Slovenian: Prepričajte se, da je podčrtana 10 na sredini okenca za odmerjanje.
English: Mean daily blood glucose values were similar between immediate-release exenatide and insulin.
Slovenian: Povprečne dnevne vrednosti glukoze v krvi so bile podobne pri eksenatidu v obliki s takojšnjim sproščanjem in insulinu.
English: Its use is commonly associated with gastrointestinal adverse reactions, including nausea, vomiting, and diarrhoea.
Slovenian: Uporabo zdravila pogosto povezujejo z neželenimi učinki na prebavila, vključno z navzeo, bruhanjem in diarejo.
English: Once in use: Store below 25 ºC for 30 days.
Slovenian: Po začetku uporabe: 30 dni shranjujte pri temperaturi do 25 ºC.
English: 10 mcg: Each pre-filled pen contains 60 doses (approximately 2.4 ml of solution).
Slovenian: 10 µg: En napolnjen injekcijski peresnik vsebuje 60 odmerkov (približno 2,4 ml raztopine).
English: Read the package leaflet and pen user manual before use.
Slovenian: Pred uporabo preberite priloženo navodilo in priročnik za uporabo injekcijskega peresnika!
English: • The is in the centre of the dose window.
Slovenian: in • je v sredini okenca za odmerjanje .
English: Immediate-release exenatide is available as either a 5 mcg or a 10 mcg exenatide per dose pre-filled pen.
Slovenian: Eksenatid v obliki s takojšnjim sproščanjem je na voljo kot 5 μg ali 10 μg eksenatida na odmerek napolnjenega injekcijskega peresnika.
English: Do not reuse needles.
Slovenian: • Da. Igel ne uporabljajte ponovno.
English: 6.6 Special precautions for disposal and other handling.
Slovenian: 6.6 Posebni varnostni ukrepi za odstranjevanje in ravnanje z zdravilom
English: • Attach a new needle.
Slovenian: • Pritrdite novo iglo.
English: The incidence of withdrawal due to adverse events was 8% for immediate-release exenatide-treated patients, 3% for placebo-treated and 1% for insulin-treated patients in the long-term controlled trials (16 weeks or longer).
Slovenian: Incidenca prekinitve zdravljenja zaradi neželenih učinkov v dolgoročnih nadzorovanih preskušanjih (16 tednov ali dlje) je bila pri bolnikih zdravljenih z eksenatidom v obliki s takojšnjim sproščanjem 8 %, 3 % pri bolnikih, ki so dobivali placebo in 1 % pri bolnikih zdravljenih z insulinom.
English: INR should be closely monitored during initiation and dose increase of immediate-release exenatide therapy in patients on warfarin and/or cumarol derivatives (see section 4.8).
Slovenian: Pri bolnikih, ki jemljejo varfarin in/ali derivate kumarola, je med uvajanjem zdravljenja in višanjem odmerka eksenatida v obliki s takojšnjim sproščanjem, potrebno skrbno nadzorovati INR (glejte poglavje 4.8).
English: Most adverse reactions associated with immediate-release exenatide were mild to moderate in intensity.
Slovenian: Večina neželenih učinkov, povezanih z eksenatidom v obliki s takojšnjim sproščanjem, je bila blaga do srednje huda.
English: ABOUT INJECTION NEEDLES
Slovenian: IGLE ZA INJICIRANJE
English: Note: If you do not see liquid after 4 times, see Commonly Asked Questions, number 3, in Section 4 of this user manual.
Slovenian: Opomba: Če po 4 poskusih tekočine ne vidite, glejte Pogosta vprašanja, številka 3, v Poglavju 4 tega Priročnika za uporabo.
English: The proportion of patients achieving HbA1c < 7% was 47.9% with immediate-release exenatide and 42.8% with insulin lispro.
Slovenian: Z eksenatidom v obliki s takojšnjim sproščanjem je HbA1c < 7 % doseglo 47,9 % bolnikov, z insulinom lispro pa 42,8 % bolnikov.
English: When immediate-release exenatide was used in combination with a sulphonylurea, the incidence of hypoglycaemia was increased over that of placebo in combination with a sulphonylurea.
Slovenian: Pri uporabi eksenatida v obliki s takojšnjim sproščanjem v kombinaciji s sulfonilsečnino je bila incidenca hipoglikemije večja v primerjavi s placebom v kombinaciji s sulfonilsečnino.